RxDoctor Payments Data

Heather Hancock, MD

Ophthalmology · Jackson, MSNPI 1821120072

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $34,050 of the $38,597 with a category attached, or 88.2%. Mallinckrodt Hospital Products Inc. accounts for 93.1% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $21,724, more than ten times the $145 reported in 2019. Among ophthalmology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,597in general payments, 2019–2025

Across 180 payments — averaging $214.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$36K
  • AbbVie$626
  • Alcon$432
  • Apellis Pharmaceuticals, Inc.$344
  • Regeneron Healthcare Solutions, Inc.$338
  • ANI Pharmaceuticals, Inc.$207
  • plus $712 from 9 others

What the payments were for

  • Speaking & faculty fees$34,05088%
  • Travel & lodging$1330%
  • Food & beverage$4,36911%
  • Gifts$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,597 in reported general payments places this provider in the 95th percentile of 150 ophthalmology providers in Mississippi.

See all ophthalmology providers in Mississippi

Medicare billing

Part B allowed, 2024
$711,651
Medicare patients
1,480
Services billed
11,045

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate390$10,585
Ketorolac Tromethamine491$7,509
Difluprednate16$2,128
Eplerenone27$1,782
Brimonidine Tartrate229$1,333
Travoprost11$1,331
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat104$1,210
Latanoprost140$865
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha66$695
MoxifloxacinMoxifloxacin Hcl29$517
Doxycycline Hyclate16$339
Dorzolamide Hcl23$276
ErythromycinErythromycin Base24$240
Timolol Maleate29$186

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →